AXIM Biotechnologies, Inc. (OTCMKTS:AXIM – Get Free Report) saw a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 90,412 shares, an increase of 373.7% from the August 31st total of 19,085 shares. Based on an average daily trading volume, of 566,486 shares, the days-to-cover ratio is presently 0.2 days.
AXIM Biotechnologies Price Performance
Shares of AXIM remained flat at $0.00 during mid-day trading on Friday. The stock had a trading volume of 20,460 shares, compared to its average volume of 285,686. AXIM Biotechnologies has a 12 month low of $0.00 and a 12 month high of $0.03.
AXIM Biotechnologies Company Profile
AXIM Biotechnologies, Inc is a biotechnology company focused primarily on diagnostic technologies, with an emphasis on ophthalmology and diseases that can be identified through biomarkers in tears. The company has developed diagnostic platforms intended to support the detection and monitoring of conditions such as dry eye disease.
AXIM’s ophthalmic development programs have included rapid, point-of-care tests designed to measure biomarkers associated with inflammation and other ocular conditions.
See Also
- Five stocks we like better than AXIM Biotechnologies
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
- BlackBerry Shifts Gears With Coretura Deal
- NVIDIA’s Next AI Chip Ramp Could Open the Door to Another Major Stock Move
- Super Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the Test
Receive News & Ratings for AXIM Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXIM Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
